ROCKVILLE, MD — (Marketwire) — 09/26/11 — MarketResearch.com has announced the addition of the new report “Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets” to their collection of Pharmaceuticals market reports. For more information, visit
There are many benefits to contract manufacturing. Pharmaceutical companies are finding that outsourcing their production abroad brings them, amongst others, cost and time savings. However, production outside an organization does not come without risks. An organization must identify the factors that make it competitive in the marketplace. It is only when a company can maintain its core competencies that outsourcing is effective.
The global pharmaceutical contract manufacturing and contract research organizations revenue reached $196 billion in 2010, it will further grow to $218 billion in 2011 and is projected to reach $361 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11%.
Contract manufacturing of OTC and nutritional products worldwide reached $115 billion in 2010, it will further grow to $128 billion in 2011 and is projected to reach $214 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11%.
Contract manufacturing of bulk and dosage form drugs worldwide reached $49 billion in 2010, it will further grow to $53 billion in 2011 and is projected to reach $86 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10%.
For more information, visit
MarketResearch.com is the leading provider of global market intelligence products and services. With over 300,000 research reports from more than 700 top consulting and advisory firms, MarketResearch.com offers instant online access to the world-s most extensive database of expert insights on global industries, companies, products, and trends. For more information, call Veronica Franco at 240-747-3016 or visit .
Contact:
Veronica Franco
MarketResearch.com
240.747.3016
You must be logged in to post a comment Login